2019 Porphyria (Erythropoietic Protoporphyri) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 50 pages | ID: 2AEAFE35CE2EN
VPAResearch

Abstracts

The global clinical trial report- “2019 Porphyria (Erythropoietic Protoporphyri) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Porphyria (Erythropoietic Protoporphyri). It presents in-depth analysis of Porphyria (Erythropoietic Protoporphyri) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Porphyria (Erythropoietic Protoporphyri).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Porphyria (Erythropoietic Protoporphyri) clinical trials by-

• Current Trial Status
• Type of the trial
• Sponsor Type
• Enrollment Trends
• Region
• Countries
• Trial Phase

The report also identifies the potential drug candidates under development for treatment of Porphyria (Erythropoietic Protoporphyri)

The research work is prepared through extensive and continuous research on Porphyria (Erythropoietic Protoporphyri) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:

• All major trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Porphyria (Erythropoietic Protoporphyri) patients are identified
• The report includes panorama of Porphyria (Erythropoietic Protoporphyri) clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Porphyria (Erythropoietic Protoporphyri) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Porphyria (Erythropoietic Protoporphyri) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Porphyria (Erythropoietic Protoporphyri) Clinical Trials by Region
  2.2.2 Average Enrollment of Porphyria (Erythropoietic Protoporphyri) Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Porphyria (Erythropoietic Protoporphyri) Treatment, 2019

3. REGION WISE PORPHYRIA (ERYTHROPOIETIC PROTOPORPHYRI) CLINICAL TRIALS

3.1 Asia Pacific Porphyria (Erythropoietic Protoporphyri) Clinical Trials by Country
3.2 Europe Porphyria (Erythropoietic Protoporphyri) Clinical Trials by Country
3.3 North America Porphyria (Erythropoietic Protoporphyri) Clinical Trials by Country
3.4 Middle East and Africa Porphyria (Erythropoietic Protoporphyri) Clinical Trials by Country
3.5 South and Central America Porphyria (Erythropoietic Protoporphyri) Clinical Trials by Country

4. PORPHYRIA (ERYTHROPOIETIC PROTOPORPHYRI) CLINICAL TRIAL TRENDS

4.1 Start Year wise Porphyria (Erythropoietic Protoporphyri) Clinical Trials
4.2 Phase wise Porphyria (Erythropoietic Protoporphyri) Clinical Trials
4.3 Trial Status wise Porphyria (Erythropoietic Protoporphyri) Clinical Trials
4.4 Trial Type wise Porphyria (Erythropoietic Protoporphyri) Clinical Trials

5. PORPHYRIA (ERYTHROPOIETIC PROTOPORPHYRI) AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Porphyria (Erythropoietic Protoporphyri) Trials by Year
5.2 Average Enrollment in Porphyria (Erythropoietic Protoporphyri) Trials by Phase
5.3 Average Enrollment in Porphyria (Erythropoietic Protoporphyri) Trials by Status
5.4 Average Enrollment in Porphyria (Erythropoietic Protoporphyri) Trials by Type of Trial

6. COMPANIES PARTICIPATING IN PORPHYRIA (ERYTHROPOIETIC PROTOPORPHYRI) CLINICAL TRIALS

6.1 Porphyria (Erythropoietic Protoporphyri) Trials by Sponsor Type
6.2 Porphyria (Erythropoietic Protoporphyri) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Porphyria (Erythropoietic Protoporphyri) Trials- Phase
7.2 Porphyria (Erythropoietic Protoporphyri) Trials- Phase
7.3 Porphyria (Erythropoietic Protoporphyri) Trials- Phase
7.4 Porphyria (Erythropoietic Protoporphyri) Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Porphyria (Erythropoietic Protoporphyri) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Porphyria (Erythropoietic Protoporphyri) Clinical Trials and Enrolment
Figure 5: Europe – Country wise Porphyria (Erythropoietic Protoporphyri) Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Porphyria (Erythropoietic Protoporphyri) Clinical Trials and Enrolment
Figure 7: North America – Country wise Porphyria (Erythropoietic Protoporphyri) Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Porphyria (Erythropoietic Protoporphyri) Clinical Trials and Enrolment
Figure 9: Porphyria (Erythropoietic Protoporphyri) Clinical Trials by Phase
Figure 10: Porphyria (Erythropoietic Protoporphyri) Clinical Trials by Trial Status
Figure 11: Porphyria (Erythropoietic Protoporphyri) Clinical Trials by Type
Figure 12: Porphyria (Erythropoietic Protoporphyri) Clinical Trials by Sponsor Type
Figure 13: Porphyria (Erythropoietic Protoporphyri) Clinical Trials by Leading Sponsors
Figure 14: Porphyria (Erythropoietic Protoporphyri) Average Enrollment by Phase
Figure 15: Porphyria (Erythropoietic Protoporphyri) Average Enrollment by Trial Status
Figure 16: Porphyria (Erythropoietic Protoporphyri) Average Enrollment by Type
Figure 17: Porphyria (Erythropoietic Protoporphyri)- Average Enrolment by Type of Sponsors
Figure 18: Porphyria (Erythropoietic Protoporphyri)- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Porphyria (Erythropoietic Protoporphyri) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Porphyria (Erythropoietic Protoporphyri) Clinical Trials and Enrolment
Table 5: Europe – Country wise Porphyria (Erythropoietic Protoporphyri) Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Porphyria (Erythropoietic Protoporphyri) Clinical Trials and Enrolment
Table 7: North America – Country wise Porphyria (Erythropoietic Protoporphyri) Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Porphyria (Erythropoietic Protoporphyri) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Porphyria (Erythropoietic Protoporphyri) Average Enrollment by Phase
Table 15: Porphyria (Erythropoietic Protoporphyri) Average Enrollment by Trial Status
Table 16: Porphyria (Erythropoietic Protoporphyri) Average Enrollment by Type
Table 17: Porphyria (Erythropoietic Protoporphyri)- Average Enrolment by Type of Sponsors
Table 18: Porphyria (Erythropoietic Protoporphyri)- Enrolment by Leading Sponsors